{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:26:37Z","timestamp":1789687597527,"version":"4.0.1"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["KSP-14OK19"],"award-info":[{"award-number":["KSP-14OK19"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>CKD is characterized by increased extracellular volume and salt-sensitive hypertension, but it is unknown whether dietary or pharmacologic approaches are preferable to reduce sodium in CKD, and if distal diuretics are still effective at lower eGFRs. In a randomized crossover trial in patients with CKD stage G3 or G4 and hypertension, the authors compared dietary sodium restriction with a combination of distal diuretics (hydrochlorothiazide and amiloride). Both interventions effectively lowered 24-hour BP and extracellular volume, with diuretics exerting a stronger effect. Although the tubular secretion of diuretics was impaired at a lower eGFR, the reductions in body weight and BP effect were maintained. These findings indicate that even at lower eGFRs, use of distal diuretics is as effective as dietary sodium restriction in treating hypertension and volume overload in CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Distal diuretics are considered less effective than loop diuretics in CKD. However, data to support this perception are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To investigate whether distal diuretics are noninferior to dietary sodium restriction in reducing BP in patients with CKD stage G3 or G4 and hypertension, we conducted a 6-week, randomized, open-label crossover trial comparing amiloride\/hydrochlorothiazide (5 mg\/50 mg daily) with dietary sodium restriction (60 mmol per day). Antihypertension medication was discontinued for a 2-week period before randomization. We analyzed effects on BP, kidney function, and fluid balance and related this to renal clearance of diuretics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 26 patients (with a mean eGFR of 39 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ) completed both treatments. Dietary sodium restriction reduced sodium excretion from 160 to 64 mmol per day. Diuretics produced a greater reduction in 24-hour systolic BP (SBP; from 138 to 124 mm Hg) compared with sodium restriction (from 134 to 129 mm Hg), as well as a significantly greater effect on extracellular water, eGFR, plasma renin, and aldosterone. Both interventions resulted in a similar decrease in body weight and NT-proBNP. Neither approaches decreased albuminuria significantly, whereas diuretics did significantly reduce urinary angiotensinogen and\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      2-microglobulin excretion. Although lower eGFR and higher plasma indoxyl sulfate correlated with lower diuretic clearance, the diuretic effects on body weight and BP at lower eGFR were maintained. During diuretic treatment, higher PGE2 excretion correlated with lower free water clearance, and four patients developed mild hyponatremia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Distal diuretics are noninferior to dietary sodium restriction in reducing BP and extracellular volume in CKD. Diuretic sensitivity in CKD is maintained despite lower diuretic clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial registry name and registration number<\/jats:title>\n                    <jats:p>DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease (DD), NCT02875886<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2019090905","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T15:45:19Z","timestamp":1580312719000},"page":"650-662","source":"Crossref","is-referenced-by-count":49,"title":["A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease"],"prefix":"10.1681","volume":"31","clinical-trial-number":[{"clinical-trial-number":"nct02875886","registry":"10.18810\/clinical-trials-gov","type":"results"},{"clinical-trial-number":"nct02875886","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dominique M.","family":"Bov\u00e9e","sequence":"first","affiliation":[{"name":"Divisions of Nephrology and Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley J.","family":"Visser","sequence":"additional","affiliation":[{"name":"Dietetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Middel","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Department of Pharmaceutical Sciences, University Utrecht, Utrecht, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"De Mik\u2013van Egmond","sequence":"additional","affiliation":[{"name":"Dietetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1074","authenticated-orcid":false,"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Department of Pharmaceutical Sciences, University Utrecht, Utrecht, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G. M.","family":"Russel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. Jan","family":"Danser","sequence":"additional","affiliation":[{"name":"Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[{"name":"Divisions of Nephrology and Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-3571","authenticated-orcid":false,"given":"Ewout J.","family":"Hoorn","sequence":"additional","affiliation":[{"name":"Divisions of Nephrology and Transplantation,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.kint.2019.06.017","article-title":"Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease","volume":"96","author":"Faucon","year":"2019","journal-title":"Kidney Int"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"e010278","DOI":"10.1161\/JAHA.118.010278","article-title":"Extracellular fluid volume is an independent determinant of uncontrolled and resistant hypertension in chronic kidney disease: A nephroTest cohort study","volume":"7","author":"Vidal-Petiot","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfm542","article-title":"Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease","volume":"23","author":"Essig","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B5-20230819","first-page":"CD010070","article-title":"Altered dietary salt intake for people with chronic kidney disease","volume":"2","author":"McMahon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2215\/CJN.01120216","article-title":"A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD","volume":"12","author":"Saran","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2369-15-57","article-title":"A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients","volume":"15","author":"Campbell","year":"2014","journal-title":"BMC Nephrol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A randomized trial of dietary sodium restriction in CKD","volume":"24","author":"McMahon","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp1905244","article-title":"Sodium-intake reduction and the food industry","volume":"381","author":"Henney","year":"2019","journal-title":"N Engl J Med"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.CIR.23.2.200","article-title":"Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics","volume":"23","author":"Reubi","year":"1961","journal-title":"Circulation"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jash.2016.02.008","article-title":"Is there a preferred diuretic class for patients with renal impairment and hypertension?","volume":"10","author":"Izzo","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1958.tb46769.x","article-title":"Chlorothiazide in renal disease","volume":"71","author":"Schreiner","year":"1958","journal-title":"Ann N Y Acad Sci"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000314542","article-title":"Changes in the sodium and potassium transporters in the course of chronic renal failure","volume":"115","author":"Kim","year":"2010","journal-title":"Nephron, Physiol"},{"key":"B15-20230819","first-page":"F257","article-title":"Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys","volume":"277","author":"Kwon","year":"1999","journal-title":"Am J Physiol"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"F199","DOI":"10.1152\/ajprenal.00018.2017","article-title":"Adaptive changes in GFR, tubular morphology, and transport in subtotal nephrectomized kidneys: Modeling and analysis","volume":"313","author":"Layton","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.1978.03630350054016","article-title":"Use of diuretics in treatment of hypertension secondary to renal disease","volume":"138","author":"Bank","year":"1978","journal-title":"Arch Intern Med"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000358603","article-title":"Chlorthalidone for poorly controlled hypertension in chronic kidney disease: An interventional pilot study","volume":"39","author":"Agarwal","year":"2014","journal-title":"Am J Nephrol"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(79)92278-5","article-title":"Double-blind trial of antihypertensive effect of chlorothiazide in severe renal failure","volume":"2","author":"Jones","year":"1979","journal-title":"Lancet"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","article-title":"A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease","volume":"14","author":"Dussol","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0002-8703(83)90123-0","article-title":"Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment","volume":"106","author":"Acchiardo","year":"1983","journal-title":"Am Heart J"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cpt1977225part1499","article-title":"Do diuretics have antihypertensive properties independent of natriuresis?","volume":"22","author":"Bennett","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM195711212572103","article-title":"Effect of chlorothiazide on the edema of cirrhosis, nephrosis, congestive heart failure and chronic renal insufficiency","volume":"257","author":"Schreiner","year":"1957","journal-title":"N Engl J Med"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.113.02793","article-title":"Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function","volume":"63","author":"Cirillo","year":"2014","journal-title":"Hypertension"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00635709","article-title":"Limitation on the use of amiloride in early renal failure","volume":"28","author":"Knauf","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"B26-20230819","first-page":"93","article-title":"Amiloride-sensitive and amiloride-insensitive kaliuresis in advanced chronic kidney disease","volume":"21","author":"Levy Yeyati","year":"2008","journal-title":"J Nephrol"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/HCO.0000000000000188","article-title":"Thiazides in advanced chronic kidney disease: Time for a randomized controlled trial","volume":"30","author":"Sinha","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11906-014-0525-x","article-title":"Thiazide diuretics in chronic kidney disease","volume":"17","author":"Sinha","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jash.2016.02.006","article-title":"Thiazides are useful agents in CKD","volume":"10","author":"Sinha","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11906-012-0293-4","article-title":"Thiazide and thiazide-like diuretics: An opportunity to reduce blood pressure in patients with advanced kidney disease","volume":"14","author":"Karadsheh","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1573402111666141231150213","article-title":"The use of thiazides in chronic kidney disease","volume":"10","author":"Karadsheh","year":"2014","journal-title":"Curr Hypertens Rev"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory distal reabsorption drives diuretic resistance in human heart failure","volume":"28","author":"Rao","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"key":"B34-20230819","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","article-title":"Diuretic resistance","volume":"69","author":"Hoorn","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","article-title":"Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): A parallel-group, double-blind randomised phase 4 trial","volume":"4","author":"Brown","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B36-20230819","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00424-014-1661-5","article-title":"Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria","volume":"467","author":"Svenningsen","year":"2015","journal-title":"Pflugers Arch"},{"key":"B37-20230819","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: A scientific statement from the American heart association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"B38-20230819","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41598-019-40416-w","article-title":"Performance of 24-hour urinary creatinine excretion-estimating equations in relation to measured 24-hour urinary creatinine excretion in hospitalized hypertensive patients","volume":"9","author":"J\u0119drusik","year":"2019","journal-title":"Sci Rep"},{"key":"B39-20230819","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med 155: 408, 2011]","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B40-20230819","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.HYP.29.6.1240","article-title":"Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I","volume":"29","author":"de Lannoy","year":"1997","journal-title":"Hypertension"},{"key":"B41-20230819","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.108.123042","article-title":"Aliskiren accumulates in Renin secretory granules and binds plasma prorenin","volume":"52","author":"Krop","year":"2008","journal-title":"Hypertension"},{"key":"B42-20230819","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpha.2017.03.007","article-title":"Simultaneous quantification of amiloride and hydrochlorothiazide in human plasma by liquid chromatography-tandem mass spectrometry","volume":"7","author":"Shah","year":"2017","journal-title":"J Pharm Anal"},{"key":"B43-20230819","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1073\/pnas.1821809116","article-title":"Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion","volume":"116","author":"Jansen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B44-20230819","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton Neurosci"},{"key":"B45-20230819","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0015-0282(16)47547-3","article-title":"Prostaglandins in semen and their relationship to male fertility: A study of 145 men","volume":"41","author":"Cosentino","year":"1984","journal-title":"Fertil Steril"},{"key":"B46-20230819","first-page":"276","article-title":"On the proper use of the crossover design in clinical trials: Part 18 of a series on evaluation of scientific publications","volume":"109","author":"Wellek","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"B47-20230819","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1979.tb05903.x","article-title":"The two-period cross-over clinical trial","volume":"8","author":"Hills","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"B48-20230819","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI89812","article-title":"Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia","volume":"127","author":"Ware","year":"2017","journal-title":"J Clin Invest"},{"key":"B49-20230819","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11906-012-0326-z","article-title":"Urinary markers of intrarenal renin-angiotensin system activity in vivo","volume":"15","author":"Roksnoer","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"B50-20230819","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy","year":"2010","journal-title":"Am J Nephrol"},{"key":"B51-20230819","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00004872-199204000-00006","article-title":"Arterial effects of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, crossover study","volume":"10","author":"Benetos","year":"1992","journal-title":"J Hypertens"},{"key":"B52-20230819","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"B53-20230819","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B54-20230819","doi-asserted-by":"crossref","first-page":"26715","DOI":"10.1038\/srep26715","article-title":"Bioengineered kidney tubules efficiently excrete uremic toxins","volume":"6","author":"Jansen","year":"2016","journal-title":"Sci Rep"},{"key":"B55-20230819","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1755.2001.060003882.x","article-title":"Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes","volume":"60","author":"Cal\u00f2","year":"2001","journal-title":"Kidney Int"},{"key":"B56-20230819","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.HYP.32.6.1071","article-title":"Thiazide-induced vasodilation in humans is mediated by potassium channel activation","volume":"32","author":"Pickkers","year":"1998","journal-title":"Hypertension"},{"key":"B57-20230819","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MNH.0000000000000479","article-title":"New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature","volume":"28","author":"Mutchler","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B58-20230819","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/HJH.0000000000000736","article-title":"Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans","volume":"33","author":"Lenders","year":"2015","journal-title":"J Hypertens"},{"key":"B59-20230819","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.2015.249","article-title":"Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease","volume":"88","author":"Morales","year":"2015","journal-title":"Kidney Int"},{"key":"B60-20230819","first-page":"56","article-title":"Long-term diuretic therapy in patients with chronic renal failure","volume":"48","author":"Cakalaroski","year":"1997","journal-title":"Clin Nephrol"},{"key":"B61-20230819","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"B62-20230819","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch Intern Med"},{"key":"B63-20230819","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1592\/phco.29.9.1061","article-title":"Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease","volume":"29","author":"Abe","year":"2009","journal-title":"Pharmacotherapy"},{"key":"B64-20230819","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5414\/CPP47525","article-title":"Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease","volume":"47","author":"Abe","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B65-20230819","doi-asserted-by":"crossref","first-page":"F135","DOI":"10.1152\/ajprenal.00388.2015","article-title":"An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney","volume":"310","author":"Arias","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B66-20230819","doi-asserted-by":"crossref","first-page":"e56215","DOI":"10.1371\/journal.pone.0056215","article-title":"Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy","volume":"8","author":"Arias","year":"2013","journal-title":"PLoS One"},{"key":"B67-20230819","doi-asserted-by":"crossref","first-page":"F1810","DOI":"10.1152\/ajprenal.00521.2006","article-title":"Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5\/6 ablation model","volume":"292","author":"Fujihara","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"B68-20230819","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/hr.2014.110","article-title":"Impact of combined losartan\/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension","volume":"37","author":"Fujisaki","year":"2014","journal-title":"Hypertens Res"},{"key":"B69-20230819","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10157-014-0981-2","article-title":"Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease","volume":"19","author":"Hoshino","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"B70-20230819","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1681\/ASN.2016040407","article-title":"Effects of vitamin D receptor activation and dietary sodium restriction on residual albuminuria in CKD: The ViRTUE-CKD trial","volume":"28","author":"Keyzer","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B71-20230819","doi-asserted-by":"crossref","first-page":"d4366","DOI":"10.1136\/bmj.d4366","article-title":"Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: Randomised controlled trial","volume":"343","author":"Slagman","year":"2011","journal-title":"BMJ"},{"key":"B72-20230819","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B73-20230819","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"key":"B74-20230819","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.115.07012","article-title":"On the origin of urinary renin: A translational approach","volume":"67","author":"Roksnoer","year":"2016","journal-title":"Hypertension"},{"key":"B75-20230819","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2013.02.365","article-title":"Thiazide-associated hyponatremia: A population-based study","volume":"62","author":"Rodenburg","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B76-20230819","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI78558","article-title":"Integrated compensatory network is activated in the absence of NCC phosphorylation","volume":"125","author":"Grimm","year":"2015","journal-title":"J Clin Invest"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019090905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:15Z","timestamp":1786131015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019090905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2019090905","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}